Browse All

Current Filters

CLEAR FILTER x

TITLE

exPDite-2: A Phase Three, Randomized, Sham-controlled, Double-blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease

Author:Abid, Nauman   Adera, Mathews   Louie-Gao, Melinda   Belfort, Gabriel   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.008  

Author Institution:BlueRock Therapeutics, Cambridge, MA